• Transparency Seal
  • Major Programs & Projects
  • Contact Us
Republic of Philippines - Office of the President
  • About DDB
    • DDB History
    • Mandate
    • Composition of the Board
    • Officials
    • The DDB Secretariat
    • DDB Hymn
    • RA 9165
    • FAQs
  • Preventive Education
    • Preventive Education and Advocacy Programs
    • Request for IEC Materials
    • Request for Capacity Building and Advocacy Programs
  • Legal Services
    • Treatment and Rehabilitation
    • Regulatory Control
  • Research & Statistics
    • Statistics
    • Researches
      • Drug Smuggling in the Philippines
      • Social and Economic Cost Allowing Access to Medical Cannabis
      • Effectiveness of the DARE Program
  • Issuances
    • Board Regulations
    • Board Resolutions
Select Page

Advisory for July 02, 2023

by Mapru Admin | Jul 3, 2023 | Advisory | 0 comments

The Dangerous Drugs Board is not affiliated with or does not have any kind of business relationship with DDB Group Philippines.

Search

Recent Posts

  • Advisory for December 6, 2025
  • Advisory for December 4-5, 2025
  • DDB Chairperson – Secretary Oscar Valenzuela shares his message for the 2025 Drug Abuse Prevention and Control (DAPC) Week
  • Advisory for November 14, 2025
  • READ: DDB UNVEILS WEEKLONG DAPC 2025 EVENTS TO PROMOTE MENTAL HEALTH, DRUG PREVENTION, AND COMMUNITY WELLNESS NATIONWIDE

REPUBLIC OF THE PHILIPPINES

All content is in the public domain unless otherwise stated.

ABOUT GOVPH

Learn more about the Philippine government, its structure, how government works and the people behind it.

  • GOV.PH
  • Open Data Portal
  • Official Gazette

GOVERNMENT LINKS

  • Office of the President
  • Office of the Vice President
  • Senate of the Philippines
  • House of Representatives
  • Supreme Court
  • Court of Appeals
  • Sandiganbayan

 

×
X
CAPTCHA Image